Results 71 to 80 of about 2,481,651 (309)

Investigating transcription factor dynamics in health and disease using FRAP

open access: yesFEBS Letters, EarlyView.
FRAP analysis of GFP‐tagged transcription factors reveals how molecular mobility and target engagement change in response to drug treatment. By combining live‐cell imaging, quantitative model fitting, and statistical analysis, this approach uncovers transcription factor dynamics linked to disease mechanisms, providing a powerful framework for ...
Kannan Govindaraj   +3 more
wiley   +1 more source

Comparisons of the QLICP-HN and FACT-H&N instruments for measuring quality of life in patients with head and neck cancer

open access: yesFrontiers in Oncology
BackgroundTwo head and neck cancer quality-of-life(QoL) measurement tools, the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N) and the Quality of Life Instruments for Cancer Patients-Head and Neck Cancer (QLICP-HN), are widely used ...
Fan Shen   +6 more
doaj   +1 more source

[Texas Instruments Press Releases, April-June 1960]

open access: yes, 1960
1. Release dated April 1, 1960 is in regard to the removal of security wraps from a TI-developed radar system, the APQ-55. A sample image of maps generated by the radar is included. 2.
Texas Instruments Incorporated
core  

Structure‐forward targeting of claudins with synthetic binders

open access: yesFEBS Letters, EarlyView.
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley   +1 more source

[Texas Instruments Press Releases, April-July 1965]

open access: yes, 1965
1. Release dated April 22, 1965 is in regard to record first-quarter sales and earnings for TI. A condensed statement of income is included. 2. Release dated April 23, 1965 announces the appointment of Frederick E.
Texas Instruments Incorporated
core  

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Una perspectiva prosopogràfica dels oficis musicals de la Catedral de València en temps de Guillem de Podio, 1480-1505

open access: yesAnuario Musical, 2017
La actividad musical anterior al siglo XVI en la catedral de Valencia es muy poco conocida. El presente estudio trata de avanzar en el conocimiento de la cuestión dirigiendo el foco de atención hacia los colectivos de personas que desempeñaron los ...
Francesc Villanueva Serrano
doaj   +1 more source

[Texas Instruments Press Releases, August-September 1970]

open access: yes, 1970
1. Press release dated August 14, 1970 from the Texas Instruments Limited subsidiary of TI announces the availability of a Dual Retriggerable Monostable package, the SN54/74123N. A diagram is included. 2.
Texas Instruments Incorporated
core  

Liver organoids: modelling complexity in homeostasis and disease

open access: yesFEBS Letters, EarlyView.
Studying liver in vitro has been challenging because simple 2D cell cultures fail to capture liver's cellular and architectural complexity. To bridge this gap, scientists increasingly use organoids, 3D liver models which better mimic liver composition and function. This review examines recent advances in liver organoid complexity and realism, discusses
Anna M. Dowbaj, Meritxell Huch
wiley   +1 more source

Acknowledgement to Reviewers of Instruments in 2019

open access: yesInstruments, 2020
Instruments Editorial Office
doaj   +1 more source

Home - About - Disclaimer - Privacy